Development and Pilot Testing of an Addiction Clinic-Based PrEP Adherence Intervention for Women with Substance Use Disorders

Status: Recruiting
Location: See location...
Intervention Type: Other, Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to test an addiction-clinic based behavioral intervention for increasing PrEP uptake and adherence among women who engage in high-risk sexual behaviors and problematic substance use. The main question it aims to answer is: • If the integrated intervention increase PrEP uptake and adherence compared to standard treatment Participants will * receive provision of PrEP information through 4 counseling sessions * prevention navigation * receive nurse practitioner prescribed PrEP in an addiction treatment setting Researchers will compare intervention group with standard treatment to see if the integrated intervention help increase PrEP uptake and adherence

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: f
View:

• Black/African American and Hispanic/Latina cisgender women

• diagnosed with a Substance use disorder (SUD) per Diagnostic and Statistical Manual of Mental Illnesses (DSM)-5 criteria

• HIV negative

• sexually active with an opposite sex partner within the past 6 months

• not using PrEP for HIV prevention at the time of screening

• able to speak, read, and write in English; and

• own or have regular access to a smart phone.

Locations
United States
Texas
Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston
RECRUITING
Houston
Contact Information
Primary
Angela Heads, PhD
Angela.M.Heads@uth.tmc.edu
(713) 486-2830
Backup
Kaixuan An
Kaixuan.An@uth.tmc.edu
(713) 486-2531
Time Frame
Start Date: 2022-06-07
Estimated Completion Date: 2025-05-30
Participants
Target number of participants: 60
Treatments
Experimental: Intervention
Active_comparator: Standard of care treatment
Related Therapeutic Areas
Sponsors
Leads: The University of Texas Health Science Center, Houston

This content was sourced from clinicaltrials.gov